BRPI0419257A - process for preparing 5,6-dihydro-4- (s) - (ethylamino) -6- (s) -methyl-4h-thieno {2,3b} thio pyran-2-sulfonamide-7,7-dioxide hydrochloride - Google Patents
process for preparing 5,6-dihydro-4- (s) - (ethylamino) -6- (s) -methyl-4h-thieno {2,3b} thio pyran-2-sulfonamide-7,7-dioxide hydrochlorideInfo
- Publication number
- BRPI0419257A BRPI0419257A BRPI0419257-5A BRPI0419257A BRPI0419257A BR PI0419257 A BRPI0419257 A BR PI0419257A BR PI0419257 A BRPI0419257 A BR PI0419257A BR PI0419257 A BRPI0419257 A BR PI0419257A
- Authority
- BR
- Brazil
- Prior art keywords
- ethylamino
- dihydro
- methyl
- thieno
- sulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Abstract
PROCESSO PARA PREPARAR CLORIDRATO DE 5,6-DIIDRO-4-(S)-(ETILAMINO)-6-(S)-METIL-4H-TIENO¢2,3b!TIOPI RANO- 2-SULFONAMIDA-7,7-DIóXIDO. A presente invenção refere-se a um processo aperfeiçoado para a preparação de cloridrato de 5,6-diidro-4-(S)-(etilamino)-6-(S)-metil-4H- tieno¢2,3b!tiopirano-2-sulfonamida-7,7-dióxido de fórmula (I) comumente conhecido como Cloridrato de Dorzolamida útil como um agente para reduzir a pressão intra-ocular por inibição da enzima anidrase carbónica.PROCESS FOR PREPARING 5,6-DIHYDRO-4- (S) - (ETHYLAMINO) -6- (S) -METHYL-4H-TIENO ¢ 2,3b! TIOPI RANO-2-SULPHONAMIDE-7,7-DIOXIDE CHLORIDE. The present invention relates to an improved process for the preparation of 5,6-dihydro-4- (S) - (ethylamino) -6- (S) -methyl-4H-thieno [2,3b] thiopyran-2-one hydrochloride. 2-sulfonamide-7,7-dioxide of formula (I) commonly known as Dorzolamide Hydrochloride useful as an agent for reducing intraocular pressure by inhibiting the carbonic anhydrase enzyme.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2004/000420 WO2006070387A1 (en) | 2004-12-28 | 2004-12-28 | PROCESS FOR PREPARING 5,6-DIHYDRO-4-(S)-(ETHYLAMINO)-6-(S) METHYL-4H-THIENO[2,3b]THIOPYRAN-2-SULPHONAMIDE-7,7-DIOXIDE HCI |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0419257A true BRPI0419257A (en) | 2008-05-06 |
Family
ID=34960556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0419257-5A BRPI0419257A (en) | 2004-12-28 | 2004-12-28 | process for preparing 5,6-dihydro-4- (s) - (ethylamino) -6- (s) -methyl-4h-thieno {2,3b} thio pyran-2-sulfonamide-7,7-dioxide hydrochloride |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1841774A1 (en) |
AU (1) | AU2004326111A1 (en) |
BR (1) | BRPI0419257A (en) |
MX (1) | MX2007007923A (en) |
WO (1) | WO2006070387A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1838717A2 (en) * | 2005-01-18 | 2007-10-03 | Teva Gyógyszergyár Zártköruen Muködo Részvenytarsaság | Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
WO2012120086A1 (en) * | 2011-03-10 | 2012-09-13 | Zach System S.P.A. | Asymmetric reduction process |
ITMI20121165A1 (en) * | 2012-07-03 | 2014-01-04 | Zach System Spa | ASYMMETRICAL REDUCTION PROCESS |
CN111233887A (en) * | 2018-11-28 | 2020-06-05 | 武汉武药科技有限公司 | Synthesis process of dorzolamide hydrochloride intermediate |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863922A (en) * | 1984-12-12 | 1989-09-05 | Merck & Co., Inc. | Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use |
US5157129A (en) * | 1990-04-18 | 1992-10-20 | Merck & Co., Inc. | Enantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide |
TW265343B (en) * | 1993-03-22 | 1995-12-11 | Merck & Co Inc |
-
2004
- 2004-12-28 WO PCT/IN2004/000420 patent/WO2006070387A1/en active Application Filing
- 2004-12-28 AU AU2004326111A patent/AU2004326111A1/en not_active Abandoned
- 2004-12-28 BR BRPI0419257-5A patent/BRPI0419257A/en not_active Application Discontinuation
- 2004-12-28 EP EP04816672A patent/EP1841774A1/en not_active Withdrawn
- 2004-12-28 MX MX2007007923A patent/MX2007007923A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1841774A1 (en) | 2007-10-10 |
AU2004326111A1 (en) | 2006-07-06 |
MX2007007923A (en) | 2007-11-14 |
WO2006070387A1 (en) | 2006-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006084217A3 (en) | Rnai-mediated inhibition of ocular hypertension targets | |
TW200700070A (en) | Enhanced bimatoprost ophthalmic solution | |
WO2007140385A3 (en) | Thiazole compounds as cannabinoid receptor ligands and uses thereof | |
MX358682B (en) | Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators. | |
WO2008011131A3 (en) | Amide compounds | |
WO2008005229A3 (en) | Process for making ophthalmic lenses | |
WO2010147957A3 (en) | Dithiol compounds, derivatives, and uses therefor | |
WO2007064914A8 (en) | 5-(arylsulfonyl)-pyrazolopiperidines | |
WO2007025103A3 (en) | Organic compounds for treating reduced dopamine receptor signalling activity | |
BRPI0412347A (en) | 2-Aminophenyl-4-phenylpyridines as kinase inhibitors | |
TW200718692A (en) | Dihydrobenzofuran derivatives and uses thereof | |
NO20062062L (en) | Processes for the preparation of various forms of (S) - (+) - clopidogrel bisulfate | |
BRPI0517390A (en) | process for the preparation of [1,4,5] -oxadiazepine derivatives | |
WO2008127381A3 (en) | Artemisinin derivatives | |
BRPI0507979A (en) | process for preparing a compound | |
PT1745010E (en) | Substituted cyclohexyl-1,4-diamine derivatives | |
WO2007082262A3 (en) | Novel compounds | |
BR0208534A (en) | Process for preparing 4,6-diaminopyrimid [5,4-d] pyrimidines | |
BRPI0419257A (en) | process for preparing 5,6-dihydro-4- (s) - (ethylamino) -6- (s) -methyl-4h-thieno {2,3b} thio pyran-2-sulfonamide-7,7-dioxide hydrochloride | |
PE20081511A1 (en) | PIPERIDINE-DERIVED COMPOUNDS AS ANTIBACTERIALS | |
TW200719889A (en) | Amino acid derivatives | |
WO2008081476A3 (en) | Process for preparing duloxetine hydrochloride | |
WO2007098393A3 (en) | Compounds and methods for treating diseases with trpv4 channel receptors | |
MY157434A (en) | Method for improving bioavailability of latanoprost | |
WO2007023395A3 (en) | Benzo[b]furane and benzo[b]thiophene derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |